Can I read HCC Risk After DAA Therapy for HCV on EtoBox?

HCC Risk After DAA Therapy for HCV by ElsayedSaad is a document available to read on EtoBox.

What is HCC Risk After DAA Therapy for HCV about?

This document reviews the relationship between hepatocellular carcinoma (HCC) and direct-acting antiviral (DAA) therapy for hepatitis C virus (HCV) infection. While DAAs have shown high rates of sustained virological response and improved safety, concerns have emerged regarding an unexpected increase in HCC occurrence and recurrence post-treatment. The review aims to analyze recent studies and identify risk factors associated with HCC following DAA therapy, highlighting the ongoing debate in the medical com

Author

ElsayedSaad

Language

EN